Drug information for SOLARAZE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
GEL; TOPICAL
3%
Prescription
(Reference Drug)
DICLOFENAC SODIUM
Diclofenac
FOUGERA PHARMS
21005
2011-12-14 Letter
2011-12-14 Label
2007-06-07 Letter
2004-07-28 Letter
2004-03-24 Letter
2003-07-08 Review
2003-05-29 Label
2003-05-29 Letter
2000-10-16 Letter
2000-10-16 Label
Drug Adverse Effects information for SOLARAZE
Role code
Indications
Reaction
# Reports
C
BLOOD PRESSURE
DYSPNOEA
1
C
BLOOD PRESSURE
HYPERTENSION
1
C
HYPERLIPIDAEMIA
CEREBRAL VENOUS THROMBOSIS
1
C
HYPERLIPIDAEMIA
DEEP VEIN THROMBOSIS
1
C
HYPERLIPIDAEMIA
INJURY
1
C
HYPERLIPIDAEMIA
PAIN
1
C
HYPERTENSION
CEREBRAL VENOUS THROMBOSIS
1
C
HYPERTENSION
DEEP VEIN THROMBOSIS
1
C
HYPERTENSION
INJURY
1
C
HYPERTENSION
PAIN
1
C
OSTEOARTHRITIS
DYSPNOEA
1
C
OSTEOARTHRITIS
HYPERTENSION
1
C
PREMENSTRUAL SYNDROME
CEREBRAL VENOUS THROMBOSIS
4
C
PREMENSTRUAL SYNDROME
DEEP VEIN THROMBOSIS
4
C
PREMENSTRUAL SYNDROME
INJURY
4
C
PREMENSTRUAL SYNDROME
PAIN
4
Ads by Google